Jun 19, 2018 ... Therefore, all of the communications were protected by the ... FTC v. Boehringer Ingelheim Pharmaceuticals, Inc., No. 16-5356 (D.C. Cir. 2018).
Jun 19, 2018 ... Boehringer Ingelheim Pharmaceuticals, Inc. Warren D. ... alleged infringer, rather than the other way around.” FTC v. Actavis, Inc., 570 U.S. 136, 141 (2013). .... All of those communications are protected by the attorney-client ...
Parties, docket activity and news coverage of federal case AbbVie Inc. et al v. Boehringer Ingelheim International GMBH et al, case number 1:17-cv-01065, from Delaware Court. ... Pharma Cases To Watch In 2018's Home Stretch. Drugmakers ...
Jun 6, 2018 ... Boehringer Ingelheim Pharmaceuticals, Inc., et al., No. ... lack of an antidote for the anticoagulant is a design defect (Claude R. Knight, et al. v.
NAIK v. BOEHRINGER INGELHEIM PHARMACEUTICALS INCORPORATED ... was fired by his employer, Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI), ... 621 et seq., and Title VII of the Civil Rights Act of 1964, 42 U.S.C. §§ 2000e et seq. ... At a sales meeting in early 2005, Somers informed all district managers that ...
Feb 9, 2016 ... For example, in Boehringer Ingelheim Pharma Gmbh et al v. Kremers Urban Pharmaceuticals, Inc. (D.N.J., 1:13-cv-01580), lawyers from Foley & Lardner represented ... Angela C. Ni; Eric W. Dittmann; Jason T. Christiansen.